Skip to content

Invesco

US · IVZ #1217 by market cap Listed 1970
30.50 +0.12 +0.40%
Live - 5344 symbols - heartbeat 541s ago · 2026-10-08 07:07
Pre-market 30.88 +1.25%
After-hours 30.40 -0.33%
Market cap
13.47B
P/B
1.35
EPS
-1.60
Reader sentiment Are you bullish or bearish on IVZ?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 11 analysts

Buy
Avg price target 34.75 +13.9%
Price target rangecurrent 30.50
Low29.50
Avg34.75
High39.00
Buy 36% Hold 64% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-09-25 Morgan Stanley -- HOLD 31.00
2026-09-11 TD Cowen -- BUY 39.00
2026-09-11 Evercore -- HOLD 37.00
2026-09-09 KBW -- BUY 39.00
2026-08-14 TD Cowen -- BUY 39.00
2026-08-13 TD Cowen -- BUY 39.00
2026-08-10 Evercore -- HOLD 35.00
2026-08-07 TD Cowen -- BUY 37.00
2026-08-05 BofA Securities -- HOLD 38.00
2026-07-29 Morgan Stanley -- HOLD 30.00
2026-07-29 Barclays -- HOLD 32.00
2026-07-29 J.P. Morgan -- HOLD 29.50
2026-07-28 Argus Research -- HOLD --
2026-07-28 Goldman Sachs -- HOLD 33.00
2026-07-28 RBC Capital -- BUY 35.00
2026-07-26 RBC Capital -- BUY 33.00
2026-07-23 RBC Capital -- BUY 33.00
2026-07-14 Goldman Sachs -- HOLD 31.00
2026-07-14 Barclays -- HOLD 31.00
2026-07-13 BMO Capital -- BUY 34.00
2026-07-10 Evercore -- HOLD 32.00
2026-07-02 RBC Capital -- BUY 31.00
2026-06-26 Morgan Stanley -- HOLD 29.00
2026-06-10 TD Cowen -- BUY 33.00
2026-06-08 TD Cowen -- BUY 33.00

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Buy
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

✦ Quant Analyst Revision Trend how this is computed

Mixed
1 1
■ Upgrades■ Downgrades
  • 1 upgrade vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Argus Research moved from Buy to Hold on 2026-04-29.

Recent rating changes

DateFirmChangeTarget
2026-04-29 Argus Research BUY → HOLD --
2026-01-21 RBC Capital HOLD → BUY 35.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-07-28 -- ±6.95% -2.26% (in line)
2026/Q1 2026-04-28 -- ±7.75% +1.49% (in line)
2025/Q4 2026-01-27 -- ±7.07% -5.13% (in line)
2025/Q3 2025-10-28 -- ±6.76% +2.13% (in line)
2025/Q2 2025-07-22 -- ±9.42% +5.20% (in line)
2025/Q1 2025-04-22 -- ±13.66% +8.27% (in line)
2024/Q4 2025-01-28 -- ±8.76% +8.96% (beat)
2024/Q3 2024-10-22 -- ±11.12% +0.11% (in line)
2024/Q2 2024-07-23 -- ±9.08% +1.88% (in line)
2024/Q1 2024-04-23 -- ±8.68% -6.42% (in line)
2023/Q4 2024-01-23 -- ±8.45% -8.28% (in line)
2023/Q3 2023-10-24 -- ±9.14% +4.07% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-08 07:07:22 · For reference only, not investment advice and not tailored to your situation.